These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1536 related articles for article (PubMed ID: 31746405)

  • 1. Identification of potential hub genes related to the progression and prognosis of hepatocellular carcinoma through integrated bioinformatics analysis.
    Song X; Du R; Gui H; Zhou M; Zhong W; Mao C; Ma J
    Oncol Rep; 2020 Jan; 43(1):133-146. PubMed ID: 31746405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
    Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
    Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
    [No Abstract]   [Full Text] [Related]  

  • 3. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
    Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
    Gene; 2019 May; 698():9-18. PubMed ID: 30825595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Potential Hub Genes Related to Diagnosis and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma via Integrated Bioinformatics Analysis.
    Tang Y; Zhang Y; Hu X
    Biomed Res Int; 2020; 2020():4251761. PubMed ID: 33376723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Screening core genes and cyclin B2 as a potential diagnosis, treatment and prognostic biomarker of hepatocellular carcinoma based on bioinformatics analysis].
    Yang SY; Ren H; Li CF; Tang H
    Zhonghua Gan Zang Bing Za Zhi; 2020 Sep; 28(9):773-783. PubMed ID: 33053978
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of Multiple Hub Genes and Pathways in Hepatocellular Carcinoma: A Bioinformatics Analysis.
    Liu J; Han F; Ding J; Liang X; Liu J; Huang D; Zhang C
    Biomed Res Int; 2021; 2021():8849415. PubMed ID: 34337056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role of microRNA‑223‑3p in the tumorigenesis of hepatocellular carcinoma: A comprehensive study based on data mining and bioinformatics.
    Zhang R; Zhang LJ; Yang ML; Huang LS; Chen G; Feng ZB
    Mol Med Rep; 2018 Feb; 17(2):2211-2228. PubMed ID: 29207133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Hub Genes and Analysis of Prognostic Values in Hepatocellular Carcinoma by Bioinformatics Analysis.
    Xu L; Tong T; Wang Z; Qiang Y; Ma F; Ma X
    Am J Med Sci; 2020 Apr; 359(4):226-234. PubMed ID: 32200915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated Bioinformatics Analysis for the Screening of Hub Genes and Therapeutic Drugs in Hepatocellular Carcinoma.
    Su Q; Li W; Zhang X; Wu R; Zheng K; Zhou T; Dong Y; He Y; Wang D; Ran J
    Curr Pharm Biotechnol; 2023; 24(8):1035-1058. PubMed ID: 35762549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis.
    Shen S; Kong J; Qiu Y; Yang X; Wang W; Yan L
    J Cell Biochem; 2019 Jun; 120(6):10069-10081. PubMed ID: 30525236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of 5 Hub Genes Related to the Early Diagnosis, Tumour Stage, and Poor Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma by Bioinformatics Analysis.
    Qiang R; Zhao Z; Tang L; Wang Q; Wang Y; Huang Q
    Comput Math Methods Med; 2021; 2021():9991255. PubMed ID: 34603487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction and analysis of weighted genes in hepatocellular carcinoma using bioinformatics analysis.
    Zhang Q; Sun S; Zhu C; Zheng Y; Cai Q; Liang X; Xie H; Zhou J
    Mol Med Rep; 2019 Apr; 19(4):2479-2488. PubMed ID: 30720105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of hub genes involved in the occurrence and development of hepatocellular carcinoma via bioinformatics analysis.
    Mi N; Cao J; Zhang J; Fu W; Huang C; Gao L; Yue P; Bai B; Lin Y; Meng W; Li X
    Oncol Lett; 2020 Aug; 20(2):1695-1708. PubMed ID: 32724412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatics analysis reveals meaningful markers and outcome predictors in HBV-associated hepatocellular carcinoma.
    Zhang L; Makamure J; Zhao D; Liu Y; Guo X; Zheng C; Liang B
    Exp Ther Med; 2020 Jul; 20(1):427-435. PubMed ID: 32537007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening and Functional Prediction of Key Candidate Genes in Hepatitis B Virus-Associated Hepatocellular Carcinoma.
    Chen X; Liao L; Li Y; Huang H; Huang Q; Deng S
    Biomed Res Int; 2020; 2020():7653506. PubMed ID: 33102593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of hub genes in hepatocellular carcinoma using integrated bioinformatic analysis.
    Hua S; Ji Z; Quan Y; Zhan M; Wang H; Li W; Li Y; He X; Lu L
    Aging (Albany NY); 2020 Mar; 12(6):5439-5468. PubMed ID: 32213663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of potential biomarkers of peripheral blood mononuclear cell in hepatocellular carcinoma using bioinformatic analysis: A protocol for systematic review and meta-analysis.
    Peng JL; Wu JZ; Li GJ; Wu JL; Xi YM; Li XQ; Wang L
    Medicine (Baltimore); 2021 Jan; 100(2):e24172. PubMed ID: 33466191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated Transcriptomic Analysis Revealed Hub Genes and Pathways Involved in Sorafenib Resistance in Hepatocellular Carcinoma.
    Jiang X; Zhang W; Li L; Xie S
    Pathol Oncol Res; 2021; 27():1609985. PubMed ID: 34737677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDK1, CCNB1, CDC20, BUB1, MAD2L1, MCM3, BUB1B, MCM2, and RFC4 May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis.
    Yang WX; Pan YY; You CG
    Biomed Res Int; 2019; 2019():1245072. PubMed ID: 31737652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 77.